Patents by Inventor Julie Lindemann

Julie Lindemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080175888
    Abstract: Disclosed is a combination of an Actinidia preparation and one or more steroids, and the use of such a combination to prevent and/or treat allergic and non-allergic inflammatory conditions or diseases, to alleviate at least one symptom of such conditions or diseases, and/or to regulate an immune response in a mammal.
    Type: Application
    Filed: January 16, 2008
    Publication date: July 24, 2008
    Inventors: Julie Lindemann, Nancy Ellen Fogg-Johnson, Patti Cronin, Gil Belofsky, Dean P. Stull
  • Publication number: 20020010211
    Abstract: Cancer in a mammal can be treated or prevented by administering to a mammal in need thereof a cancer inhibiting amount of metabolite(s) of &agr;-linolenic acid, such as stearidonic acid (18:4 n-3), eicosatetraenoic acid (20:4 n-3), docosapentaenoic acid (22:5 n-3) and mixtures thereof, especially metabolites including stearidonic acid.
    Type: Application
    Filed: July 13, 2001
    Publication date: January 24, 2002
    Inventors: Mark Obukowicz, Ayman Kabakibi, Susan L. Green, Lisa M. Olson, Julie Lindemann
  • Patent number: 6340705
    Abstract: Cancer in a mammal can be treated or prevented by administering to a mammal in need thereof a cancer inhibiting amount of metabolite(s) of &agr;-linolenic acid, such as stearidonic acid (18:4 n-3), eicosatetraenoic acid (20:4 n-3), docosaptentaenic acid (22:5 n-3) and mixtures thereof, especially metabolites including stearidonic acid.
    Type: Grant
    Filed: September 10, 1999
    Date of Patent: January 22, 2002
    Assignee: Monsanto Technology, LLC
    Inventors: Mark Obukowicz, Ayman Kabakibi, Susan L. Green, Lisa M. Olson, Julie Lindemann